PURPOSE: To evaluate the efficacy of conductive keratoplasty in the treatment of pre-existing and surgically induced hyperopic @entity940 . METHODS: In this prospective, noncomparative case series, four eyes of four subjects, two female and two male (age 25 to 47 yr) were treated for @entity3467 (up to +5.50 D) and hyperopic @entity940 (up to +5.75 D) with the Refractec ViewPoint conductive keratoplasty system. The follow-up period was 6 months. Uncorrected and spectacle-corrected visual acuity, manifest and cycloplegic refraction, and videokeratographs were obtained before and after surgery. We treated two @entity1 who had already had LASIK, one of them with a decentered ablation and the other with flap striae, one @entity1 after PRK, and one @entity1 with @entity9042 . RESULTS: No complications were observed. No eye lost lines of spectacle-corrected visual acuity. All eyes showed improvement of uncorrected visual acuity of 3 or more lines. Videokeratographs demonstrated improved centration and reduction in keratometric power readings. Each eye was analyzed separately, including a comparative analysis of the proposed nomograms and quality of vision after surgery. CONCLUSIONS: Conductive keratoplasty may be a minimally invasive solution for @entity1 with irregular hyperopic @entity940 , offering improved quality of vision in instances of flap striae by tightening the central cornea.

Conductive keratoplasty to correct hyperopic XXXX .

@entity940 :: ('MESH:D001251', 'Disease') :: ['astigmatism'] @entity3467 :: ('MESH:D006956', 'Disease') :: ['hyperopia'] @entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity9042 :: ('MESH:D007640', 'Disease') :: ['keratoconus']
@entity940 :: (MESH:D001251,Disease) :: ['astigmatism']
